(Q38927030)

English

Olanzapine inhibits proliferation, migration and anchorage-independent growth in human glioblastoma cell lines and enhances temozolomide's antiproliferative effect

scientific article published on 19 December 2014

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

7 September 2017

Olanzapine inhibits proliferation, migration and anchorage-independent growth in human glioblastoma cell lines and enhances temozolomide's antiproliferative effect (English)

1 reference

Europe PubMed Central

PubMed publication ID

7 September 2017

1 reference

based on heuristic

inferred from title

Georg Karpel-Massler

1

object named as

Georg Karpel-Massler

0 references

Klaus-Michael Debatin

10

object named as

Klaus-Michael Debatin

0 references

Marc-Eric Halatsch

11

object named as

Marc-Eric Halatsch

0 references

Mike-Andrew Westhoff

object named as

Mike-Andrew Westhoff

3

0 references

Christian Rainer Wirtz

object named as

Christian Rainer Wirtz

9

0 references

2

object named as

Richard Eric Kast

1 reference

Europe PubMed Central

PubMed publication ID

7 September 2017

4

object named as

Annika Dwucet

1 reference

Europe PubMed Central

PubMed publication ID

7 September 2017

Lisa Nonnenmacher

6

object named as

Lisa Nonnenmacher

1 reference

Europe PubMed Central

PubMed publication ID

7 September 2017

7

object named as

Michal Hlavac

1 reference

Europe PubMed Central

PubMed publication ID

7 September 2017

Markus David Siegelin

8

object named as

Markus David Siegelin

1 reference

Europe PubMed Central

PubMed publication ID

7 September 2017

author name string

Nathalie Welscher

5

1 reference

Europe PubMed Central

PubMed publication ID

7 September 2017

publication date

19 December 2014

1 reference

Europe PubMed Central

PubMed publication ID

7 September 2017

Journal of Neuro-Oncology

1 reference

Europe PubMed Central

PubMed publication ID

7 September 2017

122

1 reference

Europe PubMed Central

PubMed publication ID

7 September 2017

1

1 reference

Europe PubMed Central

PubMed publication ID

7 September 2017

21-33

1 reference

Europe PubMed Central

PubMed publication ID

7 September 2017

https://scigraph.springernature.com/pub.10.1007/s11060-014-1688-7

0 references

CBTRUS statistical report: Primary brain and central nervous system tumors diagnosed in the United States in 2006-2010.

1 reference

https://api.crossref.org/works/10.1007%2FS11060-014-1688-7

21 January 2018

Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma

1 reference

https://api.crossref.org/works/10.1007%2FS11060-014-1688-7

21 January 2018

Can the therapeutic effects of temozolomide be potentiated by stimulating AMP-activated protein kinase with olanzepine and metformin?

1 reference

https://api.crossref.org/works/10.1007%2FS11060-014-1688-7

21 January 2018

Activation of AMP-activated protein kinase by temozolomide contributes to apoptosis in glioblastoma cells via p53 activation and mTORC1 inhibition

1 reference

https://api.crossref.org/works/10.1007%2FS11060-014-1688-7

21 January 2018

From the Cover: Antipsychotic drug-induced weight gain mediated by histamine H1 receptor-linked activation of hypothalamic AMP-kinase

1 reference

https://api.crossref.org/works/10.1007%2FS11060-014-1688-7

21 January 2018

Olanzapine: a critical review of recent literature

1 reference

https://api.crossref.org/works/10.1007%2FS11060-014-1688-7

21 January 2018

Clinical practice. Bipolar disorder--a focus on depression

1 reference

https://api.crossref.org/works/10.1007%2FS11060-014-1688-7

21 January 2018

The use of olanzapine for movement disorder in Huntington's disease: a first case report

1 reference

https://api.crossref.org/works/10.1007%2FS11060-014-1688-7

21 January 2018

Improvement of Huntington's disease with olanzapine and valproate

1 reference

https://api.crossref.org/works/10.1007%2FS11060-014-1688-7

21 January 2018

Impact of atypical antipsychotics on quality of life in patients with schizophrenia

1 reference

https://api.crossref.org/works/10.1007%2FS11060-014-1688-7

21 January 2018

Association of olanzapine-induced weight gain with an increase in body fat.

1 reference

https://api.crossref.org/works/10.1007%2FS11060-014-1688-7

21 January 2018

5-HT2 and D2 receptor occupancy of olanzapine in schizophrenia: a PET investigation.

1 reference

https://api.crossref.org/works/10.1007%2FS11060-014-1688-7

21 January 2018

Radioreceptor binding profile of the atypical antipsychotic olanzapine.

1 reference

https://api.crossref.org/works/10.1007%2FS11060-014-1688-7

21 January 2018

Significant dissociation of brain and plasma kinetics with antipsychotics

1 reference

https://api.crossref.org/works/10.1007%2FS11060-014-1688-7

21 January 2018

Cancer chemotherapy and cachexia: mirtazapine and olanzapine are 5-HT3 antagonists with good antinausea effects

1 reference

https://api.crossref.org/works/10.1007%2FS11060-014-1688-7

21 January 2018

Olanzapine in the management of cancer pain

1 reference

https://api.crossref.org/works/10.1007%2FS11060-014-1688-7

21 January 2018

Olanzapine for the prevention and treatment of chronic nausea and chemotherapy-induced nausea and vomiting

1 reference

https://api.crossref.org/works/10.1007%2FS11060-014-1688-7

21 January 2018

The use of olanzapine versus metoclopramide for the treatment of breakthrough chemotherapy-induced nausea and vomiting in patients receiving highly emetogenic chemotherapy

1 reference

https://api.crossref.org/works/10.1007%2FS11060-014-1688-7

21 January 2018

Olanzapine: palliative medicine update

1 reference

https://api.crossref.org/works/10.1007%2FS11060-014-1688-7

21 January 2018

Inhibition of NF-κB signaling ablates the invasive phenotype of glioblastoma

1 reference

https://api.crossref.org/works/10.1007%2FS11060-014-1688-7

21 January 2018

Analysis of individual molecular events of DNA damage response by flow- and image-assisted cytometry

1 reference

https://api.crossref.org/works/10.1007%2FS11060-014-1688-7

21 January 2018

Single-cell RNA-seq highlights intratumoral heterogeneity in primary glioblastoma

1 reference

https://api.crossref.org/works/10.1007%2FS11060-014-1688-7

21 January 2018

AMPK: a contextual oncogene or tumor suppressor?

1 reference

https://api.crossref.org/works/10.1007%2FS11060-014-1688-7

21 January 2018

AMPK regulates NADPH homeostasis to promote tumour cell survival during energy stress

1 reference

https://api.crossref.org/works/10.1007%2FS11060-014-1688-7

21 January 2018

Drug-induced activation of SREBP-controlled lipogenic gene expression in CNS-related cell lines: marked differences between various antipsychotic drugs

1 reference

https://api.crossref.org/works/10.1007%2FS11060-014-1688-7

21 January 2018

Effects of olanzapine and paroxetine on phospholipase D activity in the rat brain

1 reference

https://api.crossref.org/works/10.1007%2FS11060-014-1688-7

21 January 2018

Regulation of phospholipase D.

1 reference

https://api.crossref.org/works/10.1007%2FS11060-014-1688-7

21 January 2018

Functions and pathophysiological roles of phospholipase D in the brain

1 reference

https://api.crossref.org/works/10.1007%2FS11060-014-1688-7

21 January 2018

Neoplastic transformation and tumorigenesis associated with overexpression of phospholipase D isozymes in cultured murine fibroblasts.

1 reference

https://api.crossref.org/works/10.1007%2FS11060-014-1688-7

21 January 2018

Overexpression of phospholipase D enhances matrix metalloproteinase-2 expression and glioma cell invasion via protein kinase C and protein kinase A/NF-kappaB/Sp1-mediated signaling pathways

1 reference

https://api.crossref.org/works/10.1007%2FS11060-014-1688-7

21 January 2018

Phospholipase D2 mediates survival signaling through direct regulation of Akt in glioblastoma cells

1 reference

https://api.crossref.org/works/10.1007%2FS11060-014-1688-7

21 January 2018

Protective effects of olanzapine and haloperidol on serum withdrawal-induced apoptosis in SH-SY5Y cells

1 reference

https://api.crossref.org/works/10.1007%2FS11060-014-1688-7

21 January 2018

Atypical neuroleptics stimulate neurogenesis in adult rat brain

1 reference

https://api.crossref.org/works/10.1007%2FS11060-014-1688-7

21 January 2018

Persistence of haloperidol in human brain tissue

1 reference

https://api.crossref.org/works/10.1007%2FS11060-014-1688-7

21 January 2018

A conceptually new treatment approach for relapsed glioblastoma: coordinated undermining of survival paths with nine repurposed drugs (CUSP9) by the International Initiative for Accelerated Improvement of Glioblastoma Care

1 reference

https://api.crossref.org/works/10.1007%2FS11060-014-1688-7

21 January 2018

Identification of the human cytochromes P450 responsible for the in vitro formation of the major oxidative metabolites of the antipsychotic agent olanzapine.

1 reference

https://pubmed.ncbi.nlm.nih.gov/25524815

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Apoptosis and beyond: cytometry in studies of programmed cell death

1 reference

https://pubmed.ncbi.nlm.nih.gov/25524815

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Accumulation of metformin by tissues of the normal and diabetic mouse

1 reference

https://pubmed.ncbi.nlm.nih.gov/25524815

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Phospholipase D in cell proliferation and cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/25524815

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S11060-014-1688-7

1 reference

Europe PubMed Central

PubMed publication ID

7 September 2017

Dimensions Publication ID

0 references

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

7 September 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q38927030&oldid=2081548179"